Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.
Peñas-LLedó E, Terán E, Sosa-Macías M, Galaviz-Hernández C, Gil JP, Nair S, Diwakar S, Hernández I, Lara-Riegos J, Ramírez-Roa R, Verde I, Tarazona-Santos E, Molina-Guarneros J, Moya G, Rägo L, LLerena A. Peñas-LLedó E, et al. Among authors: moya g. Clin Ther. 2020 Aug;42(8):1595-1610.e5. doi: 10.1016/j.clinthera.2020.06.008. Epub 2020 Aug 8. Clin Ther. 2020. PMID: 32782137
Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014).
Sosa-Macias M, Moya GE, LLerena A, Ramírez R, Terán E, Peñas-LLedó EM, Tarazona-Santos E, Galaviz-Hernández C, Céspedes-Garro C, Acosta H. Sosa-Macias M, et al. Pharmacogenomics. 2015;16(7):673-6. doi: 10.2217/pgs.15.32. Epub 2015 May 1. Pharmacogenomics. 2015. PMID: 25929854 Free article.
Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
Sosa-Macías M, Teran E, Waters W, Fors MM, Altamirano C, Jung-Cook H, Galaviz-Hernández C, López-López M, Remírez D, Moya GE, Hernández F, Fariñas H, Ramírez R, Céspedes-Garro C, Tarazona-Santos E, LLerena A. Sosa-Macías M, et al. Pharmacogenomics. 2016 Nov;17(16):1741-1747. doi: 10.2217/pgs-2016-0153. Epub 2016 Oct 28. Pharmacogenomics. 2016. PMID: 27790935
Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG, Rodrigues-Soares F, Peñas-Lledó EM, Tarazona-Santos E, Fariñas H, Rodeiro I, Terán E, Grazina M, Moya GE, López-López M, Sarmiento AP, Calzadilla LR, Ramírez-Roa R, Ortiz-López R, Estévez-Carrizo FE, Sosa-Macías M, Barrantes R, LLerena A; CEIBA-Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Naranjo MG, et al. Among authors: moya ge. OMICS. 2018 Sep;22(9):575-588. doi: 10.1089/omi.2018.0114. Epub 2018 Sep 11. OMICS. 2018. PMID: 30183544
Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans.
Rodrigues-Soares F, Peñas-Lledó EM, Tarazona-Santos E, Sosa-Macías M, Terán E, López-López M, Rodeiro I, Moya GE, Calzadilla LR, Ramírez-Roa R, Grazina M, Estévez-Carrizo FE, Barrantes R, LLerena A; RIBEF Ibero-American Network of Pharmacogenetics and Pharmacogenomics. Rodrigues-Soares F, et al. Clin Pharmacol Ther. 2020 Jan;107(1):257-268. doi: 10.1002/cpt.1598. Epub 2019 Oct 7. Clin Pharmacol Ther. 2020. PMID: 31376146
High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme.
Apellániz-Ruiz M, Inglada-Pérez L, Naranjo ME, Sánchez L, Mancikova V, Currás-Freixes M, de Cubas AA, Comino-Méndez I, Triki S, Rebai A, Rasool M, Moya G, Grazina M, Opocher G, Cascón A, Taboada-Echalar P, Ingelman-Sundberg M, Carracedo A, Robledo M, Llerena A, Rodríguez-Antona C. Apellániz-Ruiz M, et al. Among authors: moya g. Pharmacogenomics J. 2015 Jun;15(3):288-92. doi: 10.1038/tpj.2014.67. Epub 2014 Nov 4. Pharmacogenomics J. 2015. PMID: 25348618
Clinical features and possible founder mutation of the 8bp duplication mutation in the SLC4A11 gene causing corneal dystrophy and perceptive deafness in three South American families.
Romero PT, Donoso R, López P, Miranda A, Rodríguez L, Chrzanowsky D, Asenjo MS, Burgos G, Villegas P, Desir J, Moya G, Herrera LM. Romero PT, et al. Among authors: moya g. Ophthalmic Genet. 2019 Apr;40(2):91-98. doi: 10.1080/13816810.2019.1571615. Epub 2019 Mar 11. Ophthalmic Genet. 2019. PMID: 30856043
114 results